SLC5A2 and type 2 diabetes mellitus: <h4>Backgrounds</h4>The safety of different sodium-glucose transporter 2 (SGLT-2) inhibitors remains uncertain due to the lack of head-to-head comparisons.<h4>Methods</h4>This network meta-analysis (NMA) was performed to compare the safety of nine SGLT-2 inhibitors in patients with type 2 diabetes (T2DM).